The role of novel biomarkers in the diagnosis and prognosis of blood cancers: A systematic review

Blood cancers, including leukemia, lymphoma, and myeloma, are complex malignancies that require early diagnosis and accurate prognosis for effective management. The identification of novel biomarkers has the potential to revolutionize the diagnosis, prognosis, and treatment of these cancers. Recent advances in molecular biology and genomics have led to the discovery of biomarkers that can improve patient outcomes through earlier detection, better prognostic predictions, and targeted therapies. This systematic review aims to evaluate the role of novel biomarkers in the diagnosis and prognosis of blood cancers, highlighting their potential impact and the challenges associated with their clinical application.

کلیدواژه ها:

Blood Cancer ، Biomarkers ، Diagnosis ، Prognosis ، Leukemia